In medicine (oncology and hematology), tumor lysis syndrome (TLS, alternative spelling tumour lysis syndrome) is a group of metabolic complications that can occur after treatment of cancer, usually lymphomas and leukemias, and sometimes even without treatment. These complications are caused by the break-down products of dying cancer cells and include hyperkalemia, hyperphosphatemia, hyperuricemia and hyperuricosuria, hypocalcemia, and consequent acute uric acid nephropathy and acute renal failure.
Read more about Tumor Lysis Syndrome: Cause and Risk Factors, Symptoms and Pathogenesis, Diagnosis, Prevention, Treatment
Famous quotes containing the word syndrome:
“[T]he syndrome known as life is too diffuse to admit of palliation. For every symptom that is eased, another is made worse. The horse leech’s daughter is a closed system. Her quantum of wantum cannot vary.”
—Samuel Beckett (1906–1989)